Use of fish oil supplements does not significantly reduce rate of failure of grafts for hemodialysis
Among patients with new synthetic arteriovenous grafts (a synthetic tube grafted between an artery and vein) for vascular access for hemodialysis, daily ingestion of fish oil did not decrease the proportion of grafts with loss of patency (remaining open) within 12 months, according to a study in the May 2 issue of JAMA. However, fish oil recipients had a longer time without thrombosis (formation of a blood clot), half the thrombosis rate, and a clinically meaningful reduction in frequency of radiological and surgical interventions.
Optimal hemodialysis requires reliable vascular access. Current options include the arteriovenous fistula [surgical creation of a connection between an artery and vein], synthetic arteriovenous graft, and central venous catheter, which in the United States are used in 55 percent, 21 percent, and 24 percent of prevalent patients receiving hemodialysis, respectively. The arteriovenous graft was the predominant vascular access type in North America during the early 1990s but fell out of favor owing to its high complication rates and associated costs.
Charmaine E. Lok, M.D., M.Sc., of the University of Toronto and Toronto General Hospital, and colleagues conducted a randomized controlled trial that compared arteriovenous graft patency and rates of thrombosis and intervention in patients with end-stage renal disease who received fish oil supplementation vs. placebo following creation of an arteriovenous graft. The study was conducted at 15 North American dialysis centers from November 2003 through December 2010, enrolling 201 adults with stage 5 chronic kidney disease (50 percent women, 63 percent white, 53 percent with diabetes), with follow-up for 12 months after graft creation. The participants were randomly allocated to receive fish oil capsules (four 1-gram capsules/day) or matching placebo on day 7 after graft creation. The primary outcome measure for the study was the proportion of participants experiencing graft thrombosis or radiological or surgical intervention during 12 months of follow-up.
The researchers found that there was no significant difference in the proportion of fish oil recipients and placebo recipients with loss of native patency (48 percent [48/99] vs. 62 percent [60/97], respectively. However, the rate of these events was significantly lower in the fish oil group. The frequency of thrombosis events was reduced by half in the fish oil group, and the frequency of corrective interventions was lower.
The 12-month event-free rate (i.e., no loss of native patency of arteriovenous graft) was 48 percent in the fish oil group, compared with 32 percent in the placebo group. The reasons for arteriovenous graft loss were similar between treatment groups. The 12-month thrombosis-free rate was higher in the fish oil group (64 percent vs. 47 percent).
The researchers note that the use of arteriovenous grafts has declined over the last 10 years, largely driven by the emphasis on use of fistulas. Arteriovenous grafts may be suitable for patients receiving hemodialysis whose veins are unsuitable for fistula creation or who have experienced prior problems with fistula nonmaturation. However, compared with functioning fistulas, arteriovenous grafts may require a 3- to 4-fold higher frequency of interventions to maintain equivalent long-term patency. Identification of safe and inexpensive agents that prolong arteriovenous graft patency and reduce the frequency of interventions to salvage graft complications might encourage increased use of grafts.
More information: JAMA. 2012;307:1809-1816
Provided by JAMA and Archives Journals
- Everyday fish oil capsule may provide kidney-related benefits May 01, 2012 | not rated yet | 0
- Drug does not increase suitability for dialysis of surgically-enlarged blood vessels May 13, 2008 | not rated yet | 0
- For CABG, use of artery from arm does not appear to be superior to vein grafts from the leg Jan 11, 2011 | not rated yet | 0
- Hemodialysis vascular access modifies the association between dialysis modality and survival Apr 21, 2011 | not rated yet | 0
- Combination of aspirin and an anti-clotting drug reduces risk of dialysis access failure May 21, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
No new human cases of the H7N9 virus have been recorded in China for a week, national health authorities said, for the first time since the outbreak began in March.
Diseases, Conditions, Syndromes 1 hour ago | not rated yet | 0
A Nobel prize-winning scientist Tuesday played down "shock-horror scenarios" that a new virus strain will emerge with the potential to kill millions of people.
Diseases, Conditions, Syndromes 1 hour ago | 5 / 5 (1) | 0
Bacteria resistant to the antibiotic colistin are also commonly resistant to antimicrobial substances made by the human body, according to a study in mBio, the online open-access journal of the American Society for Microb ...
Diseases, Conditions, Syndromes 6 hours ago | 5 / 5 (1) | 0
(AP)—Federal investigators probing the hantavirus outbreak blamed for three deaths at Yosemite National Park recommend that design changes to tent cabins and other lodging run by private concessionaires first be reviewed ...
Diseases, Conditions, Syndromes 12 hours ago | not rated yet | 0
A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...
Diseases, Conditions, Syndromes 13 hours ago | not rated yet | 0 |
(Medical Xpress)—Cardiologists have identified a trio of biomarkers that may predict which patients with heart disease have a high risk of heart attack or death in the next two years.
23 minutes ago | not rated yet | 0 |
Each day, an average of nine people are killed in the United States and more than 1,000 injured by drivers doing something other than driving.
38 minutes ago | not rated yet | 0
(Medical Xpress)—We spend about a third of our life asleep, but why we need to do so remains a mystery. In a recent publication, researchers at University of Surrey and University College London suggest a new hypothesis, ...
33 minutes ago | not rated yet | 0
(Medical Xpress)—International researchers are studying the salt intake of Indian adults to provide vital new data to aid the development of a national salt reduction strategy.
23 minutes ago | not rated yet | 0
(Medical Xpress)—Exposure to sunshine as a small child is crucial to the development of a healthy eye according to results of long-term myopia study conducted by University of Sydney researchers.
13 minutes ago | not rated yet | 0
Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.
2 hours ago | not rated yet | 0 |